March 6, 2024 · Form 4 insider transaction
Levisetti Matteo bought 260,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024.